Phase II Study of S-1 in Combination With Radiotherapy in Esophageal Squamous Cell Carcinoma

Trial Profile

Phase II Study of S-1 in Combination With Radiotherapy in Esophageal Squamous Cell Carcinoma

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 04 Feb 2017

At a glance

  • Drugs Gimeracil/oteracil/tegafur (Primary)
  • Indications Oesophageal cancer
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 06 Jan 2016 Planned End Date changed from 1 Mar 2018 to 1 Oct 2018 as reported by ClinicalTrials.gov record.
    • 06 Jan 2016 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
    • 19 Apr 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top